Growth Differentiation Factor-15 and Risk of Recurrent Events in Patients Stabilized After Acute Coronary Syndrome

Relation of Baseline High-Sensitivity C-Reactive Protein Level to Cardiovascular Outcomes With Rosuvastatin in the Justification for Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER)

(2010) Paul M. Ridker et al.   AMERICAN JOURNAL OF CARDIOLOGY

Growth differentiation factor-15 and cardiovascular dysfunction and disease: malefactor or innocent bystander?

(2010) S. Taddei et al.   EUROPEAN HEART JOURNAL

Growth-Differentiation Factor-15 for Long-Term Risk Prediction in Patients Stabilized After an Episode of Non–ST-Segment–Elevation Acute Coronary Syndrome

(2009) Kai M. Eggers et al.   Circulation-Cardiovascular Genetics

Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction

(2009) S. Q. Khan et al.   EUROPEAN HEART JOURNAL

Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study

(2009) L. Lind et al.   EUROPEAN HEART JOURNAL

Growth-Differentiation Factor-15 in Heart Failure

(2009) Tibor Kempf et al.   Heart Failure Clinics

Concentrations of C-Reactive Protein and B-Type Natriuretic Peptide 30 Days after Acute Coronary Syndromes Independently Predict Hospitalization for Heart Failure and Cardiovascular Death

(2008) B. M. Scirica et al.   CLINICAL CHEMISTRY

Growth-differentiation factor-15 for early risk stratification in patients with acute chest pain

(2008) K. M. Eggers et al.   EUROPEAN HEART JOURNAL

Gene Expression Pattern in Biomechanically Stretched Cardiomyocytes

(2007) Derk Frank et al.   HYPERTENSION